surmount-1 tirzepatide trial obesity without diabetes for Obesity: Highlights from the In the SURMOUNT-1 trial (published

Document the time and dose taken, monitor your blood glucose if you have a meter (especially if taking insulin or sulfonylureas), stay hydrated, and contact your healthcare provider or pharmacist for personalized guidance based on your medical history

Keeping your energy up by not doing extended fasts

Higher doses correlate with a greater likelihood of side effects

Robust quality assurance programs, including regular testing and documentation, are essential to demonstrate compliance and avoid enforcement actions

But here's what many people discover a few weeks in: the medication works brilliantly at reducing appetite and improving metabolic markers, yet they're noticing a bit of fatigue, worried about losing muscle along with fat, and some people dealing with persistent nausea

Typically, these candidates are individuals with a higher body mass index (BMI) who have not achieved their desired results with other antidiabetic medications